<DOC>
	<DOCNO>NCT01332409</DOCNO>
	<brief_summary>To investigate possible problem question safety effectiveness salmeterol fluticasone patient chronic obstructive pulmonary disease ( bronchitis chronic / emphysema ) . In special drug use investigation , onset pneumonia shall handle priority investigation item .</brief_summary>
	<brief_title>Special Drug Use Investigation ADOAIR DISKUS COPD ( Salmeterol Fluticasone )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<criteria>Must use salmeterol fluticasone first time Patients hypersensitivity salmeterol fluticasone Patients infection salmeterol fluticasone effective Patients deep mycosis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>